It’s not only Celgene investors who are set for a big payoff with this week’s $ 74 billion sale to Bristol-Myers Squibb. Thanks to brand-new severance agreements inked days ahead of the deal announcement, its top executives could reap hefty gains, too. Under change-in-control severance arrangements that took effect Dec. 17, top Celgene managers would… Read More »
Are Medicare Supplement Plans Worth It? Here’s Everything You Need to Know… Oct 17, 2018 by Dale Harris Senior citizens make up over 13% of the United States population and are projected to make up as much as 20% of the population by the year 2060. That growth of seniors in our country means that… Read More »
Sen. Lisa Murkowski, R-Alaska, said that limited health insurance options in her state were a primary factor in her decision to vote against a Democratic resolution that would have curtailed cheap short-term health plans promoted by the Trump administration as an alternative to Obamacare plans. The centrist GOP senator had voted several times against Obamacare… Read More »